XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents shown in balance sheets $ 72,909 $ 103,629
Marketable investments (Note 2) 51,580 19,688
Accounts receivable, net of allowance for expected credit losses of $574 and $560 as of December 31, 2023 and 2022, respectively (Note 1,13) 58,999 73,345
Deferred commissions 23,207 24,559
Prepaid expenses and other current assets 9,305 14,069
Total current assets 216,000 235,290
Property and equipment, net 19,401 23,208
Operating lease right-of-use assets 39,722 49,970
Goodwill 244,257 242,149
Intangible assets, net 37,637 49,504
Other assets 7,157 8,317
Total assets 564,174 608,438
Current Liabilities:    
Accounts payable 1,796 361
Accrued expenses and other current liabilities 81,482 91,007
Deferred revenue 156,798 178,021
Total current liabilities 240,076 269,389
Long-term debt 35,000 50,000
Non-current operating lease liabilities 37,673 50,751
Other non-current liabilities (Note 13) 11,160 16,642
Total liabilities 323,909 386,782
Commitments and contingencies (Note14)
Stockholders' Equity:    
Preferred stock, $0.01 par value Authorized - 500 shares; issued and outstanding - none 0 0
Common stock, $0.01 par value Authorized - 125,000 shares Issued - 24,684 and 24,367 shares as of December 31, 2023 and 2022, respectively Outstanding - 19,248 and 19,062 shares as of December 31, 2023 and 2022, respectively 247 244
Additional paid-in capital 278,057 261,766
Retained earnings 177,681 174,631
Treasury stock - 5,437 and 5,305 shares as of December 31, 2023 and 2022, respectively (211,149) (207,067)
Accumulated other comprehensive loss (4,571) (7,918)
Total stockholders’ equity 240,265 221,656
Total liabilities and stockholders’ equity $ 564,174 $ 608,438